Clinical impact of customised positive airway pressure (PAP) therapy interfaces (3DPiPPIn): a single site randomised controlled trial

Key Points

• Clinical impact of customised positive airway pressure therapy interfaces is significant, improving airway management.
• Trial results indicate enhanced performance with the use of customised interfaces in airway therapy.
• Randomized controlled trial conducted at a single site to assess efficacy and application.
• These findings may support wider adoption of tailored therapies for better clinical outcomes.